| Date Filed | Type | Description |
| 07/17/2023 |
4
| Glover Stephen C. (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $5.13, valued at
$46.2k
|
|
| 06/09/2023 |
4
| Glover Stephen C. (Director) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 85,000 shares
@ $0
Granted 40,000 options to buy
@ $0
Granted 17,500 options to buy
@ $0 |
|
| 05/26/2023 |
4
| Glover Stephen C. (Director) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Granted 210,000 options to buy
@ $0 |
|
| 05/19/2023 |
3
| Glover Stephen C. (Director) has filed a Form 3 on Ambrx Biopharma Inc. |
| 05/12/2023 |
SC 13D/A
| Glover Stephen C. reports a 6.8% stake in ZyVersa Therapeutics, Inc. |
| 12/22/2022 |
SC 13D
| Glover Stephen C. reports a 15.1% stake in ZyVersa Therapeutics, Inc. |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Glover Steve C (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 38,400 shares
@ $1.3, valued at
$49.9k
|
|
| 07/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/10/2019 |
3
| Glover Steve C (Director) has filed a Form 3 on PDS Biotechnology Corp |